Insider · CIK 0001780448
Barry Shin
Files at CMPX (Compass Therapeutics, Inc.). First filing -, latest -.
In brief
Barry Shin files SEC Form 4 as CFO at CMPX (Compass Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Barry Shin has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | CMPX Compass Therapeutics, Inc. | AGrant or award Common Stock | +125,000 | $5.17 | $646k | 525,000 | Jan 5, 2026 |
| Jan 2, 2026 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +670,000 | $0.00 | $0 | 670,000 | Jan 5, 2026 |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +250,000 | $0.00 | $0 | 250,000 | Feb 13, 2025 |
| Dec 9, 2024 | CMPX Compass Therapeutics, Inc. | AGrant or award Common Stock | +400,000 | $1.65 | $660k | 400,000 | Dec 10, 2024 |
| Dec 9, 2024 | CMPX Compass Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +400,000 | $0.00 | $0 | 400,000 | Dec 10, 2024 |
Questions about Barry Shin
Answered from the filings on this page, as of the latest one.
Is Barry Shin buying or selling?
Barry Shin has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Barry Shin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Barry Shin has 0.
Where does Barry Shin file Form 4?
Barry Shin has filed Form 4 at CMPX (Compass Therapeutics, Inc.) as CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.